- Home
- AVDX vs CERT Comparison
AVDX vs CERT Comparison
Compare AVDX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDX
- CERT
- Stock Information
- Founded
- AVDX 2000
- CERT 2008
- Country
- AVDX United States
- CERT United States
- Employees
- AVDX N/A
- CERT N/A
- Industry
- AVDX EDP Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- AVDX Technology
- CERT Technology
- Exchange
- AVDX Nasdaq
- CERT Nasdaq
- Market Cap
- AVDX 2.0B
- CERT 1.7B
- IPO Year
- AVDX 2021
- CERT 2020
- Fundamental
- Price
- AVDX $9.94
- CERT $10.84
- Analyst Decision
- AVDX Hold
- CERT Buy
- Analyst Count
- AVDX 14
- CERT 7
- Target Price
- AVDX $9.73
- CERT $15.00
- AVG Volume (30 Days)
- AVDX 2.1M
- CERT 1.3M
- Earning Date
- AVDX 08-06-2025
- CERT 08-06-2025
- Dividend Yield
- AVDX N/A
- CERT N/A
- EPS Growth
- AVDX N/A
- CERT N/A
- EPS
- AVDX N/A
- CERT 0.05
- Revenue
- AVDX $446,722,000.00
- CERT $405,755,000.00
- Revenue This Year
- AVDX $5.58
- CERT $12.38
- Revenue Next Year
- AVDX $9.73
- CERT $7.49
- P/E Ratio
- AVDX N/A
- CERT $218.49
- Revenue Growth
- AVDX 8.04
- CERT 11.61
- 52 Week Low
- AVDX $6.61
- CERT $8.64
- 52 Week High
- AVDX $11.68
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- AVDX 76.01
- CERT 50.18
- Support Level
- AVDX $9.89
- CERT $10.70
- Resistance Level
- AVDX $9.93
- CERT $11.16
- Average True Range (ATR)
- AVDX 0.02
- CERT 0.40
- MACD
- AVDX -0.00
- CERT 0.01
- Stochastic Oscillator
- AVDX 100.00
- CERT 38.26
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.